These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1868865)

  • 1. Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects.
    Davis LE; Kornfeld M
    Eur Neurol; 1991; 31(4):229-40. PubMed ID: 1868865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.
    Cruz M; Cruz I; Horton J
    Trans R Soc Trop Med Hyg; 1991; 85(2):244-7. PubMed ID: 1887483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
    Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL
    Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case from practice (272)--cerebral cysticercosis (neurocysticercosis)--infection with larvae of Taenia solium, swine tapeworm].
    Michel-Harder C; Gubler C
    Schweiz Rundsch Med Prax; 1993 Jul; 82(29-30):800-1. PubMed ID: 8362130
    [No Abstract]   [Full Text] [Related]  

  • 5. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
    Carpio A; Santillán F; León P; Flores C; Hauser WA
    Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial.
    Sotelo J; Escobedo F; Penagos P
    Arch Neurol; 1988 May; 45(5):532-4. PubMed ID: 3358706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurocysticercosis: a rare cause of convulsive crises].
    Domenici R; Matteucci L; Meossi C; Stefani G; Frugoli G
    Pediatr Med Chir; 1995; 17(6):577-81. PubMed ID: 8668597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurocysticercosis: a review of 65 patients].
    Alarcón Egas F; Escalante L; Suárez J; Dueñas G; Páez R; Pérez Y; Banda H; Ortiz M
    Arch Neurobiol (Madr); 1988; 51(5):252-68. PubMed ID: 3219021
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis.
    Cruz M; Cruz I; Horton J
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22 Suppl():279-83. PubMed ID: 1822906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysticercosis and epilepsy: a critical review.
    Carpio A; Escobar A; Hauser WA
    Epilepsia; 1998 Oct; 39(10):1025-40. PubMed ID: 9776322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.
    Monteiro L; Almeida-Pinto J; Stocker A; Sampaio-Silva M
    J Neurol; 1993 Nov; 241(1):15-21. PubMed ID: 8138816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocysticercosis--a review of 231 cases.
    Monteiro L; Coelho T; Stocker A
    Infection; 1992; 20(2):61-5. PubMed ID: 1582685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
    Chagnon A; Galzin M; de Jaureguiberry JP; Boyer B; Paris JF; Marlier S; Carli P
    Med Trop (Mars); 1994; 54(3):275-6. PubMed ID: 7885211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cerebral cysticercosis. A report on the treatment with praziquantel].
    Meyer-Wahl JG; Maier-Metz F
    Fortschr Med; 1984 Mar; 102(12):336-9. PubMed ID: 6714907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in treatment of neurocysticercosis.
    Agarwal AK; Dudeja RK; Chandra S
    J Assoc Physicians India; 1994 Jan; 42(1):88. PubMed ID: 7836272
    [No Abstract]   [Full Text] [Related]  

  • 18. MR observations on the effects of praziquantel in neurocysticercosis.
    Jena A; Sanchetee PC; Tripathi R; Jain RK; Gupta AK; Sapra ML
    Magn Reson Imaging; 1992; 10(1):77-80. PubMed ID: 1545685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
    Takayanagui OM; Jardim E
    Arch Neurol; 1992 Mar; 49(3):290-4. PubMed ID: 1536632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical ophthalmological presentation of neurocysticercosis in two children.
    Jethani J; Vijayalakshmi P; Kumar M
    J AAPOS; 2007 Oct; 11(5):495-6. PubMed ID: 17644440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.